Citations

Clear

135 citation(s) found for "Sim, FH".

Immobilization of vitronectin‐binding heparan sulfates onto surfaces to support human pluripotent stem cells
Yap, Lynn , Murali, Sadasivam, Bhakta, Gajadhar, Chen, Allen Kuan‐Liang, Sim, Lyn Chiin, Lim, Yu Ming , Goh, James Cho‐Hong , Oh, Steve , Choo, Andre , Wijnen, André J. van , Robinson, David E., Whittle, Jason D. , Short, Robert D. , Nurcombe, Victor , Cool, Simon M. , van Wijnen, Andre J , Titmarsh, Drew M. , Bardor, Muriel , Birch, William R.

Mayo Clinic

Journal of Biomedical Materials Research Part B: Applied Biomaterials | September 20, 2017 | Volume: 106 | Issue: 5 | Pages: 1887-1896

10.1002/jbm.b.33999 | PMID 28941021 Get It

AbstractFunctionalizing medical devices with polypeptides to enhance their performance has become important for improved clinical success. The extracellular matrix (ECM) adhesion protein vitronectin (VN) is an effective coating, although the chemistry used to attach VN often reduces its bioactivity. In vivo, VN binds the ECM in a sequence‐dependent manner with heparan sulfate (HS) glycosaminoglycans. We reasoned therefore that sequence‐based affinity chromatography could be used to isolate a VN‐binding HS fraction (HS9) for use as a coating material to capture VN onto implant surfaces. Binding avidity and specificity of HS9 were confirmed by enzyme‐linked immunosorbent assay (ELISA) and surface plasmon resonance (SPR)‐based assays. Plasma polymerization of allylamine (AA) to tissue culture‐treated polystyrene (TCPS) was then used to capture and present HS9 as determined by radiolabeling and ELISA. HS9‐coated TCPS avidly bound VN, and this layered surface supported the robust attachment, expansion, and maintenance of human pluripotent stem cells. Compositional analysis demonstrated that 6‐O‐ and N‐sulfation, as well as lengths greater than three disaccharide units (dp6) are critical for VN binding to HS‐coated surfaces. Importantly, HS9 coating reduced the threshold concentration of VN required to create an optimally bioactive surface for pluripotent stem cells. We conclude that affinity‐purified heparan sugars are able to coat materials to efficiently bind adhesive factors for biomedical applications. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 1887–1896, 2018.
Outcomes and Complications of Reconstruction with Use of Free Vascularized Fibular Graft for Spinal and Pelvic Defects Following Resection of a Malignant Tumor
Rose, Peter S. , Bakri, Karim , Wagner, Eric R. , Yaszemski, Michael J. , Sim, Franklin H. , Moran, Steven L. , Houdek, Matthew T. , Wagner, Eric R

Mayo Clinic

Journal of Bone and Joint Surgery | July 4, 2017 | Volume: 99 | Issue: 13 | Pages: e69

10.2106/jbjs.16.01458 | PMID 28678130 Get It

Background: Following resection of malignant tumors of the spine and pelvis, reconstructive surgeons often face large structural defects. Unlike reconstruction in the extremities, wherein a free vascularized fibular graft (FVFG) is a highly utilized option for segmental osseous reconstruction, there are limited data on the use of an FVFG in the spine and pelvis. The aim of this study was to review our institution’s experience with reconstruction with use of an FVFG following oncological resection in the spine and pelvis. Methods: We reviewed 24 cases involving the use of an FVFG in reconstruction of segmental osseous defects of the spine and pelvis following oncological resection from 2000 to 2015. The cohort consisted of 12 male and 12 female patients with a mean age of 37 years and a mean follow-up of 5 years. Fifty-four percent of the reconstructions were spinopelvic or sacropelvic. Results: The overall 2, 5, and 10-year rate of survival was 76%, 55%, and 37%, respectively. With regard to disease-free survival, the overall 2, 5, and 10-year rate was 81%, 72%, and 48%. The overall rate of union was 86%, with a mean time to union of 7 months. Complications were common, with 83% of the patients sustaining at least 1 postoperative complication. Following the procedure, the mean Musculoskeletal Tumor Society rating was 53%. Conclusions: An FVFG provides a durable means of reconstruction of osseous defects in the spine and pelvis. Although patient function was acceptable following these large reconstructions, the rate of postoperative complications was high. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.
Rising maternal circulating GH during murine pregnancy suggests placental regulation
Huang, Lili , Sim, Pamela Su-Lin, Roberts, Claire T. , Velhuis, Johannes D, Chen, Chen , Gatford, Kathryn L. , Mühlhäusler, Beverly Sara , Chen, C

Mayo Clinic

Endocrine Connections | April 12, 2017 | Volume: 6 | Issue: 4 | Pages: 260-266

10.1530/ec-17-0032 | PMID 28404685 Get It

Placenta-derived hormones including growth hormone (GH) in humans contribute to maternal adaptation to pregnancy, and intermittent maternal GH administration increases foetal growth in several species. Both patterns and abundance of circulating GH are important for its activity, but their changes during pregnancy have only been reported in humans and rats. The aim of the present study was to characterise circulating profiles and secretory characteristics of GH in non-pregnant female mice and throughout murine pregnancy. Circulating GH concentrations were measured in whole blood (2 μL) collected every 10 min for 6 h in non-pregnant diestrus female C57Bl/6J mice ( n = 9), and pregnant females at day 8.5–9.5 (early pregnancy, n = 8), day 12.5–13.5 (mid-pregnancy, n = 7) and day 17.5 after mating (late pregnancy, n = 7). Kinetics and secretory patterns of GH secretion were determined by deconvolution analysis, while orderliness and regularity of serial GH concentrations were calculated by approximate entropy analysis. Circulating GH was pulsatile in all groups. Mean circulating GH and total and basal GH secretion rates increased markedly from early to mid-pregnancy, and then remained elevated. Pulse frequency and pulsatile GH secretion rate were similar between groups. The irregularity of GH pulses was higher in all pregnant groups than that in non-pregnant mice. Increased circulating GH in murine pregnancy is consistent with an important role for this hormone in maternal adaptation to pregnancy and placental development. The timing of increased basal secretion from mid-pregnancy, concurrent with the formation of the chorioallantoic placenta and initiation of maternal blood flow through it, suggests regulation of pituitary secretion by placenta-derived factors.
Successful use of family‐based therapy interventions for uncontrolled type 1 diabetes in an adolescent
Wilfahrt, Robert P. , Matthews, Abigail , Lenz, Katrina R. , Sim, Leslie , Matthews, Abigail

Mayo Clinic

Practical Diabetes | April 10, 2017 | Volume: 34 | Issue: 3 | Pages: 95-98

10.1002/pdi.2091 Get It

AbstractAdolescents with type 1 diabetes mellitus (T1DM) are at increased risk for poor treatment adherence and glycaemic lability. Parental involvement in a youth's diabetes regimen is associated with better outcomes, yet supported treatments may be inaccessible due to limited community resources and financial constraints. Furthermore, existing interventions emphasise a collaborative effort between family members, which may not be effective with youth with particular vulnerabilities. Similarities between T1DM and anorexia nervosa prompted our use of modified family‐based therapy (FBT) with a 16‐year‐old male with poor glycaemic control. FBT‐guided strategies were brief and implemented by a family medicine physician at routine visits. Medical symptoms dramatically improved over a four‐month period, demonstrating that FBT tailored to T1DM warrants further investigation for youth with poor treatment adherence. Copyright © 2017 John Wiley & Sons.
Early Results of Acetabular Reconstruction After Wide Periacetabular Oncologic Resection
Roth, Philipp von , Perry, Kevin I. , Rose, Peter S. , Lewallen, David G. , Sim, Franklin H. , Abdel, Matthew P.

Mayo Clinic

Journal of Bone and Joint Surgery | February 10, 2017 | Volume: 99 | Issue: 3 | Pages: e9

10.2106/jbjs.16.00803 | PMID 28145959 Get It

Background: Reliable acetabular fixation in total hip arthroplasty following periacetabular resections is challenging. Tantalum components have been successfully implemented for difficult revision arthroplasties, but, to our knowledge, have not been reported for acetabular reconstruction following oncologic periacetabular resection. The primary purpose of the current study was to determine the early clinical outcomes, complications, and radiographic findings for acetabular reconstruction after oncologic periacetabular resection. In addition, a novel classification scheme for primary periacetabular resections and reconstructions is presented. Methods: We reviewed 10 consecutive patients treated with tantalum acetabular reconstruction following periacetabular resection. All patients had a primary acetabular malignancy including chondrosarcoma (n = 7) and osteosarcoma (n = 3). The cohort included 6 males (60%). The mean age was 54 years (range, 30 to 73 years). The mean follow-up was 59 months (range, 8 to 113 months). Results: At the most recent follow-up, 9 patients were alive and 1 had died of the respective disease. All patients obtained full ambulatory status with the use of gait aids. Postoperative complications included dislocation (n = 3), wound-healing disturbance (n = 1), and deep venous thrombosis (n = 1). Two patients underwent reoperations for recurrent dislocations. The mean postoperative Harris hip score was 75 points (range, 49 to 92 points). Conclusions: Preliminary results of tantalum reconstruction following periacetabular resections provide reasonable improvement in early clinical outcomes and stable fixation in situations with massive bone loss and compromised bone quality. As expected due to the lack of a functioning abductor mechanism from the wide oncologic resection, early dislocations remain a concern. As such, we now consider the primary use of increasing constraint, but it must be balanced with the often compromised host bone. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.
Brief Primary Care Obesity Interventions: A Meta-analysis
Sim, Leslie , Lebow, Jocelyn , Koball, Afton M. , Murad, M. Hassan , Wang, Zhen , Murad, M Hassan , Lebow, Jocelyn

Mayo Clinic

Pediatrics | September 12, 2016 | Volume: 138 | Issue: 4 | Pages: No page available

10.1542/peds.2016-0149 | PMID 27621413 Get It

CONTEXT: Although practice guidelines suggest that primary care providers working with children and adolescents incorporate BMI surveillance and counseling into routine practice, the evidence base for this practice is unclear. OBJECTIVE: To determine the effect of brief, primary care interventions for pediatric weight management on BMI. DATA SOURCES: Medline, CENTRAL, Embase, PsycInfo, and CINAHL were searched for relevant publications from January 1976 to March 2016 and cross-referenced with published studies. STUDY SELECTION: Eligible studies were randomized controlled trials and quasi-experimental studies that compared the effect of office-based primary care weight management interventions to any control intervention on percent BMI or BMI z scores in children aged 2 to 18 years. DATA EXTRACTION: Two reviewers independently screened sources, extracted data on participant, intervention, and study characteristics, z-BMI/percent BMI, harms, and study quality using the Cochrane and Newcastle-Ottawa risk of bias tools. RESULTS: A random effects model was used to pool the effect size across eligible 10 randomized controlled trials and 2 quasi-experimental studies. Compared with usual care or control treatment, brief interventions feasible for primary care were associated with a significant but small reduction in BMI z score (–0.04, [95% confidence interval, –0.08 to –0.01]; P = .02) and a nonsignificant effect on body satisfaction (standardized mean difference 0.00, [95% confidence interval, –0.21 to 0.22]; P = .98). LIMITATIONS: Studies had methodological limitations, follow-up was brief, and adverse effects were not commonly measured. CONCLUSIONS: BMI surveillance and counseling has a marginal effect on BMI, highlighting the need for revised practice guidelines and the development of novel approaches for providers to address this problem.
What Factors Are Predictive of Outcome in the Treatment of Soft Tissue Sarcomas of the Foot and Ankle?
Beahrs, Taylor R., Rose, Peter S. , Sim, Franklin H. , Turner, Norman S. , Wyles, Cody C. , Houdek, Matthew T.

Mayo Clinic

Foot & Ankle Specialist | September 1, 2016 | Volume: 10 | Issue: 1 | Pages: 12-19

10.1177/1938640016666925 | PMID 27587379 Get It

Soft tissue sarcomas of the foot and ankle are common. Currently, there exist limited data on prognostic variables. The aim of this study was to review our institution’s experience with soft tissue sarcomas of the foot and ankle to identify factors affecting outcomes and survivorship. We reviewed the records of 62 foot and ankle soft tissue sarcomas treated with definitive surgery at our institution between 1992 and 2013. The cohort consisted of 35 males and 27 females with a mean age at diagnosis of 45 years and a mean follow-up of 7 years. The most common tumor subtype was synovial sarcoma (n = 16). The overall limb salvage rate was 53%. Local recurrence was observed in 9 patients and distant metastases in 15 patients. Tumor size ≥3 cm in maximal dimension was the greatest risk factor in mortality. Posttreatment complications occurred in 15 patients. Local recurrence and development of distant disease was relatively common following wide excision of a soft tissue sarcoma of the foot and ankle. Tumors that were ≥3 cm in maximal dimension were associated with a worse overall survival and patients with neoadjuvant radiation were at increased risk of complications. Levels of Evidence: Level IV: Retrospective Case Series
Patterns of expressed emotion in adolescent eating disorders
Rienecke, Renee D. , Sim, Leslie , Lock, James , Grange, Daniel Le

Mayo Clinic

Journal of Child Psychology and Psychiatry | July 5, 2016 | Volume: 57 | Issue: 12 | Pages: 1407-1413

10.1111/jcpp.12594 | PMID 27377705 Get It

Background This goal of this study was to understand the patterns of expressed emotions (EEs) in adolescent eating disorders. As such, this study compared EE among families of adolescents with anorexia nervosa ( AN ), bulimia nervosa ( BN ), and a psychiatric control group, major depressive disorder ( MDD ). This study also examined the influence of family status (intact vs. nonintact) and the presence of siblings on EE . Methods Two‐hundred and fifteen adolescents (ages 12–19) and their families were recruited for this study including 121 adolescents with AN , 54 adolescents with BN , and 40 adolescents with MDD . Adolescents with at least one parent completed the Standardized Clinical Family Interview. Adolescents completed structured diagnostic interviews to assess eligibility for the study, as well as a standardized questionnaire to assess depression. Results Analyses revealed that fathers showed higher levels of critical comments to adolescents with BN or MDD than those with AN , whereas mothers made more critical comments toward patients with BN . Mothers made the least number of positive remarks toward patients with MDD . In terms of the influence of family status, fathers from intact families showed more expressions of warmth and were less critical than fathers from nonintact families, whereas mothers from intact families were less critical but also made fewer positive remarks than mothers from nonintact families. The presence of siblings appeared to reduce mothers’ expression of warmth and emotional overinvolvement. Conclusions Unique patterns of EE were found to characterize AN , BN , and MDD . Family status and the presence of siblings exert an influence on EE that should be taken into consideration in future research.
Functional and oncologic outcome of cemented endoprosthesis for malignant proximal femoral tumors
Watts, Chad D. , Rose, Peter S. , Taunton, Michael J. , Sim, Franklin H. , Wyles, Cody C. , Houdek, Matthew T. , Taunton, Michael J , Pagnano, Mark W

Mayo Clinic

Journal of Surgical Oncology | June 29, 2016 | Volume: 114 | Issue: 4 | Pages: 501-506

10.1002/jso.24339 | PMID 27353406 Get It